HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis and management of postoperative pulmonary hypertensive crisis.

Abstract
In this paper we discuss two infants and one child who experienced a previously unreported complication after complete correction of a large, unrestrictive ventricular septal defect. Two patients had documented pulmonary hypertensive crises and severe right-heart failure secondary to hypoxia and pulmonary vasoconstriction. These crises were associated with significantly increased right ventricular (RV) peak systolic and end-diastolic pressures and right-to-left shunting via a foramen ovale which, in turn, exaggerated the hypoxis. The crises were treated successfully with tolazoline in the second and third patients. RV pressure returned to normal values and have remained normal up to 12 months postoperatively in the second patient. Although the RV pressures decreased with tolazoline in the third patient, they never reached normal values. Postoperative monitoring of pulmonary artery and RV pressures in infants with large ventricular septal defects is essential when unexplained complications are encountered. Tolazoline proved to be very effective in the treatment of two patients with pulmonary vasoconstriction secondary to hypoxia.
AuthorsJ Wheller, B L George, D G Mulder, J M Jarmakani
JournalCirculation (Circulation) Vol. 60 Issue 7 Pg. 1640-4 (Dec 1979) ISSN: 0009-7322 [Print] United States
PMID498483 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Tolazoline
Topics
  • Heart Septal Defects, Ventricular (surgery)
  • Humans
  • Hypertension, Pulmonary (diagnosis, drug therapy, therapy)
  • Hyperventilation (diagnosis)
  • Infant
  • Infant, Newborn
  • Male
  • Postoperative Complications (diagnosis, therapy)
  • Tolazoline (administration & dosage)
  • Vascular Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: